Scaffold Therapeutics

Scaffold Therapeutics is developing small-molecule oncology therapeutics targeting the m6A RNA methylation pathway. We are advancing a pipeline of assets, developing a library of novel screening compounds, and designing proprietary cellular assays that provide insight into m6A pathway biology.